Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.7824
$0.073410.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 33.09% | 26.27% | 32.87% | -8.49% | 22.30% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.58% | 30.48% | -94.84% | -315.59% | -37.53% |
| Change in Net Operating Assets | -2,297.68% | -22.33% | -123.39% | -268.84% | -97.73% |
| Cash from Operations | -2.52% | 31.36% | -59.41% | -47.47% | -89.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -37.83% | -- |
| Total Debt Repaid | 16.04% | -- | 72.02% | -- | -- |
| Issuance of Common Stock | -39.47% | -- | -50.42% | -- | 147,717.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -37.60% | -- | -48.58% | -51.68% | 146,521.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.96% | 89.98% | -5,472.60% | -56.85% | 493.72% |